`__________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`__________________
`
`AMERIGEN PHARMACEUTICALS LIMITED and
`ARGENTUM PHARMACEUTICALS LLC,
`Petitioner,
`v.
`
`JANSSEN ONCOLOGY, INC.,
`Patent Owner
`__________________
`
`Case IPR2016-00286
`Patent 8,822,438 B21
`__________________
`
`
`
`ARGENTUM’S STIPULATED WITHDRAWAL OF
`MAHALINGAM DECLARATION
`
`
`
`
`
`
`
`
`
`
`
`
`1 Case IPR2016-01317 has been joined with this proceeding.
`
`
`
`As ordered by the Board in IPR2016-01317 (Paper 30), Argentum
`
`Pharmaceuticals LLC hereby files this stipulation that it withdraws the declaration
`
`of Dr. Devalingam Mahalingam (Ex. 1073) and relies instead on the declaration
`
`and testimony of Amerigen’s expert, Dr. Scott Serels.
`
`Date: September 30, 2016
`
`
`
`
`
`
`
`
`
`
`
`
`Respectfully submitted,
`
`
`
`/Teresa Stanek Rea/
`
`Teresa Stanek Rea
`Reg. No. 30,427
`CROWELL & MORING LLP
`Intellectual Property Group
`P.O. Box 14300
`Washington, DC 20044-4300
`
`Counsel for Argentum
`
`
`Filed on behalf of Argentum
`Pharmaceuticals by William D.
`Hare, lead counsel for Petitioner.
`
`
`
`
`
`
`
`
`CERTIFICATION OF SERVICE
`
`The undersigned hereby certifies that the foregoing document entitled
`
`ARGENTUM’S STIPULATED WITHDRAWAL OF MAHALINGAM
`
`DECLARATION was served electronically via email on September 30, 2016 to
`
`Patent Owner’s counsel of record and counsel of record for Petitioners Argentum,
`
`at the following:
`
`
`
`
`
`
`
`Patent Owner
`JANS-ZYTIGA@akingump.com
`ZytigaIPRTeam@sidey.com
`
`Petitioner Argentum
`trea@crowell.com
`slentz@crowell.com
`
`Respectfully submitted,
`
`/william hare/
`William D. Hare
`Reg. No. 44,739
`McNeely, Hare, & War LLP
`12 Roszel Road, Suite C104
`Princeton, NJ 08540
`
`